An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status
Journal article
Lumley SF. et al, (2022), Clinical Infectious Diseases, 74, 1208 - 1219
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
Journal article
Ogbe A. et al, (2022), JCI Insight, 7
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies
Journal article
Spencer AJ. et al, (2022), eBioMedicine, 77, 103902 - 103902
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Journal article
Wei J. et al, (2022), Nature Medicine
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Journal article
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
Journal article
Costa Clemens SA. et al, (2022), Lancet (London, England)
An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease
Journal article
Peng Y. et al, (2022), Nature Immunology, 23, 50 - 61
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Journal article
Stuart ASV. et al, (2022), Lancet (London, England), 399, 36 - 49
Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.
Journal article
Dejnirattisai W. et al, (2021), Lancet (London, England)
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2
Journal article
Townsend A. et al, (2021), Nature Communications, 12
Flavivirus maturation leads to the formation of an occupied lipid pocket in the surface glycoproteins
Journal article
Renner M. et al, (2021), Nature Communications, 12
Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections
Journal article
Eyre DW. et al, (2021), BMC Infectious Diseases, 21
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
Journal article
Ogbe A. et al, (2021), Nature Communications, 12
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants.
Journal article
Liu C. et al, (2021), Cell host & microbe
Human antibody C10 neutralizes by diminishing Zika but enhancing dengue virus dynamics.
Journal article
Lim X-X. et al, (2021), Cell
The epitope arrangement on flavivirus particles contributes to Mab C10's extraordinary neutralization breadth across Zika and dengue viruses.
Journal article
Sharma A. et al, (2021), Cell
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Journal article
Payne RP. et al, (2021), Cell, 184, 5699 - 5714.e11
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
Journal article
Wei J. et al, (2021), Nature Microbiology, 6, 1140 - 1149
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
Journal article
Flaxman A. et al, (2021), The Lancet, 398, 981 - 990